nach oben

Endocrine

Erschienen in:

13.05.2022 | Original Article

Association of antibiotics exposure within the first 2 years after birth with subsequent childhood type 1 diabetes

verfasst von: Dahye Lee, Seulggie Choi, Jooyoung Chang, Young Jun Park, Jae Hyun Kim, Sang Min Park

Erschienen in: Endocrine | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Antibiotics prescription in early life can cause dysbiosis, an imbalance of gut microbiota. We aimed to reveal the relationship between antibiotics exposure during the first 2 years after birth and type 1 diabetes risk in children under 8 years of age using a nationally representative data from South Korea.

Methods

The final study population consisted of 63,434 children from the National Health Insurance Service (NHIS) database from 2008 to 2015. The primary exposure of interest was antibiotics prescription in first 2 years after birth. The analysis was conducted with cumulative defined daily dose (cDDD; 0–29, 30–59, ≥ 60 cDDD), the number of antibiotics classes (0–3, 4, ≥5 classes), and age at first antibiotics prescription (0–119, 120–239, ≥ 240 days). Age, sex, household income, and overweight were considered as potential confounding covariates.

Results

Compared to those within the less than 30 cDDD, other groups that were prescribed more antibiotics did not have a significant difference in diabetes risk (aHR 0.86, 95% CI 0.37–2.02 in ≥ 60 cDDD). The number of antibiotics classes and age at first antibiotics prescriptions were also not associated with the risk of type 1 diabetes. The development of diabetes was not related to the cDDD, the number of antibiotics classes, and age at first antibiotics prescription according to subgroup analysis which was stratified by overweight.

Conclusions

Antibiotics exposure within the first 2 years of life was not associated with subsequent diabetes risk. Future studies using a larger number of long-term follow-up data are needed.

Nur mit Berechtigung zugänglich

C.C. Patterson, G.G. Dahlquist, E. Gyürüs, A. Green, G. Soltész, Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373(9680), 2027–2033 (2009). https://doi.org/10.1016/s0140-6736(09)60568-7CrossRefPubMed

D. Dabelea, E.J. Mayer-Davis, S. Saydah, G. Imperatore, B. Linder, J. Divers, R. Bell, A. Badaru, J.W. Talton, T. Crume, A.D. Liese, A.T. Merchant, J.M. Lawrence, K. Reynolds, L. Dolan, L.L. Liu, R.F. Hamman; Study, S.f.D.i.Y., Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311(17), 1778–1786 (2014). https://doi.org/10.1001/jama.2014.3201CrossRefPubMedPubMedCentral

K. Hummel, K.K. McFann, J. Realsen, L.H. Messer, G.J. Klingensmith, H.P. Chase, The increasing onset of type 1 diabetes in children. J. Pediatr. 161(4), 652–657.e651 (2012). https://doi.org/10.1016/j.jpeds.2012.03.061CrossRefPubMed

P.J. Carter, W.S. Cutfield, P.L. Hofman, A.J. Gunn, D.A. Wilson, P.W. Reed, C. Jefferies, Ethnicity and social deprivation independently influence metabolic control in children with type 1 diabetes. Diabetologia 51(10), 1835–1842 (2008). https://doi.org/10.1007/s00125-008-1106-9CrossRefPubMed

H. Zhang, W. Xia, Q. Yu, B. Wang, S. Chen, Z. Wang, E.J. Love, Increasing incidence of type 1 diabetes in children aged 0-14 years in Harbin, China (1990–2000). Prim Care. Diabetes 2(3), 121–126 (2008). https://doi.org/10.1016/j.pcd.2008.06.001CrossRef

M.E. Craig, A. Hattersley, K.C. Donaghue, Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr. Diabetes 10(Suppl 12), 3–12 (2009). https://doi.org/10.1111/j.1399-5448.2009.00568.xCrossRefPubMed

D.P., Group, Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet. Med 23(8), 857–866 (2006). https://doi.org/10.1111/j.1464-5491.2006.01925.xCrossRef

D.J. Kim, The epidemiology of diabetes in Korea. Diabetes Metab. J. 35(4), 303–308 (2011). https://doi.org/10.4093/dmj.2011.35.4.303CrossRefPubMedPubMedCentral

D. Dabelea, J.M. Stafford, E.J. Mayer-Davis, R. D’Agostino Jr., L. Dolan, G. Imperatore, B. Linder, J.M. Lawrence, S.M. Marcovina, A.K. Mottl, M.H. Black, R. Pop-Busui, S. Saydah, R.F. Hamman, C. Pihoker; Group, S.f.D.i.Y.R., Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA 317(8), 825–835 (2017). https://doi.org/10.1001/jama.2017.0686CrossRefPubMedPubMedCentral

10.

K.T. Coppieters, F. Dotta, N. Amirian, P.D. Campbell, T.W. Kay, M.A. Atkinson, B.O. Roep, M.G. von Herrath, Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 209(1), 51–60 (2012). https://doi.org/10.1084/jem.20111187CrossRefPubMedPubMedCentral

11.

C.F. Verge, R. Gianani, E. Kawasaki, L. Yu, M. Pietropaolo, H.P. Chase, G.S. Eisenbarth, R.A. Jackson, Prediction of type i diabetes in first-degree relatives using a combination of Insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45(7), 926–933 (1996). https://doi.org/10.2337/diab.45.7.926CrossRefPubMed

12.

J.S. Skyler, J.P. Krischer, J. Wolfsdorf, C. Cowie, J.P. Palmer, C. Greenbaum, D. Cuthbertson, L.E. Rafkin-Mervis, H.P. Chase, E. Leschek, Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial–type 1. Diabetes Care 28(5), 1068–1076 (2005). https://doi.org/10.2337/diacare.28.5.1068CrossRefPubMed

13.

S. Candon, A. Perez-Arroyo, C. Marquet, F. Valette, A.P. Foray, B. Pelletier, C. Milani, M. Ventura, J.F. Bach, L. Chatenoud, Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS One 10(5), e0125448 (2015). https://doi.org/10.1371/journal.pone.0125448CrossRefPubMedPubMedCentral

14.

G. Tapia, K. Stordal, K. Marild, C.R. Kahrs, T. Skrivarhaug, P.R. Njolstad, G. Joner, L.C. Stene, Antibiotics, acetaminophen and infections during prenatal and early life in relation to type 1 diabetes. Int J. Epidemiol. 47(5), 1538–1548 (2018). https://doi.org/10.1093/ije/dyy092CrossRefPubMedPubMedCentral

15.

L.C. Bailey, C.B. Forrest, P. Zhang, T.M. Richards, A. Livshits, P.A. DeRusso, Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 168(11), 1063–1069 (2014). https://doi.org/10.1001/jamapediatrics.2014.1539CrossRefPubMed

16.

F.I. Scott, D.B. Horton, R. Mamtani, K. Haynes, D.S. Goldberg, D.Y. Lee, J.D. Lewis, Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology 151(1), 120–129.e125 (2016). https://doi.org/10.1053/j.gastro.2016.03.006CrossRefPubMed

17.

Y.J. Park, J. Chang, G. Lee, J.S. Son, S.M. Park, Association of class number, cumulative exposure, and earlier initiation of antibiotics during the first two-years of life with subsequent childhood obesity. Metabolism 112, 154348 (2020). https://doi.org/10.1016/j.metabol.2020.154348CrossRefPubMed

18.

K.D. Corbin, K.A. Driscoll, R.E. Pratley, S.R. Smith, D.M. Maahs, E.J. Mayer-Davis, Advancing care for type, D., Obesity, N.: obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms. Endocr. Rev. 39(5), 629–663 (2018). https://doi.org/10.1210/er.2017-00191CrossRefPubMed

19.

K.C. Verbeeten, C.E. Elks, D. Daneman, K.K. Ong, Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis. Diabet. Med 28(1), 10–18 (2011). https://doi.org/10.1111/j.1464-5491.2010.03160.xCrossRefPubMed

20.

N. Vilarrasa, P. San Jose, M.Á. Rubio, A. Lecube, Obesity in patients with type 1 diabetes: links, risks and management challenges. Diabetes Metab. Syndr. Obes.: Targets Ther. ume 14, 2807–2827 (2021). https://doi.org/10.2147/dmso.s223618CrossRef

21.

T.J. Wilkin, The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis. Pediatr. Diabetes 13(4), 334–339 (2012). https://doi.org/10.1111/j.1399-5448.2011.00831.xCrossRefPubMed

22.

A. Kilkkinen, S.M. Virtanen, T. Klaukka, M.G. Kenward, M. Salkinoja-Salonen, M. Gissler, M. Kaila, A. Reunanen, Use of antimicrobials and risk of type 1 diabetes in a population-based mother–child cohort. Diabetologia 49(1), 66–70 (2006). https://doi.org/10.1007/s00125-005-0078-2CrossRefPubMed

23.

T.D. Clausen, T. Bergholt, O. Bouaziz, M. Arpi, F. Eriksson, S. Rasmussen, N. Keiding, E.C. Lokkegaard, Broad-spectrum antibiotic treatment and subsequent childhood type 1 diabetes: a nationwide danish cohort study. PLoS One 11(8), e0161654 (2016). https://doi.org/10.1371/journal.pone.0161654CrossRefPubMedPubMedCentral

24.

S. Cheol Seong, Y.Y. Kim, Y.H. Khang, J. Heon Park, H.J. Kang, H. Lee, C.H. Do, J.S. Song, J. Hyon Bang, S. Ha, E.J. Lee, S. Ae Shin, Data resource profile: the national health information database of the National Health Insurance Service in South Korea. Int J. Epidemiol. 46(3), 799–800 (2017). https://doi.org/10.1093/ije/dyw253CrossRefPubMed

25.

J.H. Lee, Y.M. Kim, M.J. Kwak, S.Y. Kim, H.J. Kim, C.K. Cheon, W.Y. Chung, I.J. Choi, S.Y. Hong, H.W. Chueh, J.H. Yoo, Incidence trends and associated factors of diabetes mellitus in Korean children and adolescents: a retrospective cohort study in Busan and Gyeongnam. Ann. Pediatr. Endocrinol. Metab. 20(4), 206–212 (2015). https://doi.org/10.6065/apem.2015.20.4.206CrossRefPubMedPubMedCentral

26.

T. Yatsunenko, F.E. Rey, M.J. Manary, I. Trehan, M.G. Dominguez-Bello, M. Contreras, M. Magris, G. Hidalgo, R.N. Baldassano, A.P. Anokhin, A.C. Heath, B. Warner, J. Reeder, J. Kuczynski, J.G. Caporaso, C.A. Lozupone, C. Lauber, J.C. Clemente, D. Knights, R. Knight, J.I. Gordon, Human gut microbiome viewed across age and geography. Nature 486(7402), 222–227 (2012). https://doi.org/10.1038/nature11053CrossRefPubMedPubMedCentral

27.

WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment, 2020. Oslo (2019).

28.

S.R. Daniels, S.G. Hassink, Committee On, N.: the role of the pediatrician in primary prevention of obesity. Pediatrics 136(1), e275–e292 (2015). https://doi.org/10.1542/peds.2015-1558CrossRefPubMed

29.

J.H. Kim, S. Yun, S.S. Hwang, J.O. Shim, H.W. Chae, Y.J. Lee, J.H. Lee, S.C. Kim, D. Lim, S.W. Yang, K. Oh, J.S. Moon, Committee for the Development of Growth Standards for Korean, C., Adolescents, Committee for School, H., Public Health Statistics, t.K.P.S., Division of, H., Nutrition Survey, K.C.f.D.C., Prevention: The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J. Pediatr. 61(5), 135–149 (2018). https://doi.org/10.3345/kjp.2018.61.5.135CrossRefPubMedPubMedCentral

30.

G. Chai, L. Governale, A.W. McMahon, J.P. Trinidad, J. Staffa, D. Murphy, Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics 130(1), 23–31 (2012). https://doi.org/10.1542/peds.2011-2879CrossRefPubMed

31.

P. Vangay, T. Ward, J.S. Gerber, D. Knights, Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17(5), 553–564 (2015). https://doi.org/10.1016/j.chom.2015.04.006CrossRefPubMedPubMedCentral

32.

S. Sharma, P. Tripathi, Gut microbiome and type 2 diabetes: where we are and where to go? J. Nutr. Biochem. 63, 101–108 (2019). https://doi.org/10.1016/j.jnutbio.2018.10.003CrossRefPubMed

33.

K.S.W. Leong, J.G.B. Derraik, P.L. Hofman, W.S. Cutfield, Antibiotics, gut microbiome and obesity. Clin. Endocrinol. (Oxf.) 88(2), 185–200 (2018). https://doi.org/10.1111/cen.13495CrossRef

34.

A. Paun, J.S. Danska, Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome. Pediatr. Diabetes 17(7), 469–477 (2016). https://doi.org/10.1111/pedi.12424CrossRefPubMed

35.

G.L.V. de Oliveira, A.Z. Leite, B.S. Higuchi, M.I. Gonzaga, V.S. Mariano, Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology 152(1), 1–12 (2017). https://doi.org/10.1111/imm.12765CrossRefPubMedPubMedCentral

36.

A.M. Abdellatif, N.E. Sarvetnick, Current understanding of the role of gut dysbiosis in type 1 diabetes. J. Diabetes 11(8), 632–644 (2019). https://doi.org/10.1111/1753-0407.12915CrossRefPubMed

37.

T.M. Davis, Ethnic diversity in type 2 diabetes. Diabet. Med 25(Suppl 2), 52–56 (2008). https://doi.org/10.1111/j.1464-5491.2008.02499.xCrossRefPubMed

38.

J.H. Kim, C.G. Lee, Y.A. Lee, S.W. Yang, C.H. Shin, Increasing incidence of type 1 diabetes among Korean children and adolescents: analysis of data from a nationwide registry in Korea. Pediatr. Diabetes 17(7), 519–524 (2016). https://doi.org/10.1111/pedi.12324CrossRefPubMed

39.

E.J. Mayer-Davis, J.M. Lawrence, D. Dabelea, J. Divers, S. Isom, L. Dolan, G. Imperatore, B. Linder, S. Marcovina, D.J. Pettitt, C. Pihoker, S. Saydah, L. Wagenknecht; Study, S.f.D.i.Y., Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N. Engl. J. Med 376(15), 1419–1429 (2017). https://doi.org/10.1056/NEJMoa1610187CrossRefPubMedPubMedCentral

40.

M.E. Falagas, M. Kompoti, Obesity and infection. Lancet Infect. Dis. 6(7), 438–446 (2006). https://doi.org/10.1016/s1473-3099(06)70523-0CrossRefPubMed

41.

J. Dobner, S. Kaser, Body mass index and the risk of infection–from underweight to obesity. Clin. Microbiol. Infect. 24(1), 24–28 (2018). https://doi.org/10.1016/j.cmi.2017.02.013CrossRefPubMed

42.

Y.J. Choe, J.-Y. Shin, Trends in the use of antibiotics among Korean children. Korean J. Pediatr. 62(4), 113–118 (2019). https://doi.org/10.3345/kjp.2018.07290CrossRefPubMedPubMedCentral

43.

I. Youngster, J. Avorn, V. Belleudi, A. Cantarutti, J. Diez-Domingo, U. Kirchmayer, B.J. Park, S. Peiro, G. Sanfelix-Gimeno, H. Schroder, K. Schussel, J.Y. Shin, S.M. Shin, G.S. Simonsen, H.S. Blix, A. Tong, G. Trifiro, T. Ziv-Baran, S.C. Kim, Antibiotic use in children - a cross-national analysis of 6 countries. J. Pediatr.-Us 182, 239–244 (2017). https://doi.org/10.1016/j.jpeds.2016.11.027CrossRef

Titel: Association of antibiotics exposure within the first 2 years after birth with subsequent childhood type 1 diabetes
verfasst von: Dahye Lee
Seulggie Choi
Jooyoung Chang
Young Jun Park
Jae Hyun Kim
Sang Min Park
Publikationsdatum: 13.05.2022
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 1/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-022-03042-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Correction: Prospective study on the clinical relevance of 18F-DOPA positron emission tomography/computed tomography in patients with medullary thyroid carcinoma

Levothyroxine treatment and gastric juice pH in humans: the proof of concept

Papillary thyroid carcinoma as first and isolated neoplastic disease in a Lynch syndrome family member with a germline MLH1 mutation

Intensive management of obesity in people with Prader-Willi syndrome

Predicting risk of overweight or obesity in Chinese preschool-aged children using artificial intelligence techniques